CABG patientsa(n=43,347) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Pumpb | Off pump | Kaplan Meierc | Competing risk modelc | |||||||
(n=33,357) | (n=9,990) | |||||||||
n | %d | n | %d | HRe | (95% CI) | p-value | HRe | (95% CI) | p-value | |
Cancer-specific mortality | ||||||||||
• Unadjusted model | 923 | 2.8% | 218 | 2.2% | 1.02 | (0.76-1.37) | 0.898 | 1.02 | (0.76-1.37) | 0.898 |
• Adjusted modelf | 1.13 | (0.90-1.42) | 0.306 | 1.16 | (0.92-1.46) | 0.203 | ||||
Cardiovascular-specific mortality | ||||||||||
• Unadjusted model | 2,979 | 8.9% | 754 | 7.5% | 1.01 | (0.78-1.31) | 0.938 | 1.01 | (0.78-1.31) | 0.938 |
• Adjusted modelf | 1.26 | (0.89-1.79) | 0.186 | 1.15 | (0.86-1.55) | 0.344 | ||||
Other cause-specific mortality | ||||||||||
• Unadjusted model | 1,862 | 5.6% | 491 | 4.9% | 0.94 | (0.73-1.22) | 0.658 | 0.94 | (0.73-1.22) | 0.658 |
• Adjusted modelf | 1.24 | (0.67-2.29) | 0.495 | 1.20 | (0.65-2.19) | 0.561 |